S 2810, the Retirement Freedom Act, allows individuals currently enrolled in Medicare Part A to choose to leave the program without penalty. It permits beneficiaries to later re-enroll in Medicare Part A without any financial penalty or waiting period. The bill specifically ensures that opting out of Part A does not require giving up Social Security retirement benefits (Title II) and prevents individuals from having to repay Medicare Part A costs for services received before opting out. This policy directly affects Medicare Part A beneficiaries who wish to manage their healthcare coverage options independently.
This bill prohibits federal agencies from enforcing any restrictions on firearm magazines based on their capacity (e.g., magazine size). It also invalidates state or local laws that limit or ban magazines by capacity, such as bans on magazines holding more than 10 rounds. The bill defines "capacity" as the number of rounds a magazine can hold and "firearm magazine" as a device storing ammunition for a firearm. These changes apply 30 days after the bill's enactment, removing federal and state-level capacity-based magazine restrictions.
HR 5401, the Pay Our Troops Act of 2026, ensures military personnel, civilian Defense workers, and supporting contractors receive pay during government funding gaps in fiscal year 2026. It appropriates emergency funds for active-duty service members, reserves, and their supporting personnel (including Coast Guard staff under DHS) if regular appropriations aren't enacted by the end of the fiscal year. The bill provides necessary pay and allowances during any period when full-year funding is unavailable, covering both active service and support roles. Funding expires when regular appropriations are passed, a funding resolution is enacted, or January 1, 2027, whichever comes first. This is a procedural measure to prevent pay delays for military and support staff during fiscal year 2026 funding lapses.
HR 5364, the STOP FRAUD in Medicaid Act, expands state Medicaid fraud control units' authority to investigate and prosecute fraud committed by Medicaid beneficiaries (people receiving benefits), not just healthcare providers. It amends federal law to explicitly include "individuals applying for or receiving" Medicaid services in fraud investigations, requiring states to cover both provider and beneficiary fraud. The bill directs states to investigate false applications or misuse of benefits, such as lying about income to qualify or using benefits for unauthorized services. These changes take effect 180 days after the bill becomes law, applying to all Medicaid programs nationwide. The law focuses on clarifying investigative scope without creating new penalties or funding.
This symbolic resolution (HRES 700) condemns the assassination of Charlie Kirk, a conservative campus advocate and founder of Turning Point USA, who was killed on September 10, 2025, at Utah Valley University. It expresses the House's deepest condolences to Kirk’s family, including his wife and children, and honors his work promoting civil discourse among college students. The resolution does not create new laws or policies but serves as a formal expression of the House’s stance on the incident. It directly affects no individuals or groups through legislative action, as it is purely a ceremonial statement.
The DECLINE Act requires federal agencies to immediately deactivate government payment cards (like purchase or travel cards) when employees leave their positions, including through separation, retirement, or discharge. Agencies must collect physical cards, remove them from digital wallets, and stop card usage within 30 days of an employee’s departure. This applies to all federal employees, including those in senior executive roles and policy-determining positions. Agencies must also report annually to Congress on compliance, card deactivations, and misuse prevention to prevent fraud or unauthorized spending.
HR 5316 allows pharmacists and physicians to compound drugs for urgent hospital use during shortages when commercially available alternatives are unavailable. It requires the drug to have appeared on the FDA’s shortage list within 60 days, prescriber certification of failed attempts to obtain alternatives, and specific labeling stating the drug is not FDA-approved. Hospitals must track patient administration records within 7 days and report adverse events to the FDA within 15 days. The bill also expands drug shortage reporting to include sudden demand spikes, not just manufacturing interruptions.
The Consumer Safety Technology Act (S 2766) creates three key initiatives to enhance consumer safety through emerging technologies. Title I requires the Consumer Product Safety Commission to run a pilot program using artificial intelligence for tracking product injuries, identifying hazards, and monitoring online markets for recalled items, with a mandatory report to Congress afterward. Title II directs the Commerce Secretary to study how blockchain technology can prevent fraud in consumer transactions, including public input and a report on regulatory improvements. Title III mandates the Federal Trade Commission to report on its enforcement actions against deceptive practices involving digital tokens and recommend legislative changes to strengthen consumer protections in this growing market.
The RESULTS Act (S 2761) changes how Medicare sets payment rates for clinical diagnostic laboratory tests by requiring the collection of final payment data from private payors through a qualifying comprehensive claims database. For widely available non-ADLT tests (non-Advanced Diagnostic Laboratory Tests), this new system will apply to data collection periods beginning January 1, 2027, with reporting for these periods starting January 1, 2028. If data isn't available for a test, the bill establishes a default payment rate equal to the previous year's rate adjusted for inflation. This affects Medicare, clinical laboratories, and private payors by creating more accurate, market-based payment rates that better reflect final payments made by private insurers.
The RESULTS Act (HR 5269) changes how Medicare calculates payment rates for clinical diagnostic laboratory tests. It requires Medicare to collect data on private payor rates for widely available non-Advanced Diagnostic Laboratory Tests (non-ADLTs) from a qualifying independent claims data entity (a national nonprofit organization meeting specific criteria) rather than relying on data reported directly by laboratories. For tests where data is unavailable, the bill establishes default payment rates based on previous years' rates adjusted for inflation. The law also requires Medicare to publicly explain payment rates with supporting data, affecting Medicare beneficiaries, clinical laboratories, and private payors that provide services covered by Medicare.
This bill prohibits the Environmental Protection Agency from reallocating renewable fuel requirements from small refineries that have extended exemptions under the Clean Air Act. It directly affects small refineries with extended exemptions and the companies that would otherwise cover their renewable fuel obligations. The key provision requires the EPA to include gasoline or diesel refined by these exempt small refineries in the total fuel volume calculation for the year, preventing other entities from bearing their share of the renewable fuel mandate. This changes how renewable fuel obligations are calculated to protect consumers from potential cost increases tied to reallocated requirements.
This bill directs the U.S. Department of Energy to conduct a study on how artificial intelligence (AI) and data center growth affects energy resources, with specific focus on rural and remote areas. The study will examine infrastructure needs, alternative energy sources (like solar, wind, and hydro), impacts on energy costs and reliability, and ways to speed up permitting for these facilities. It requires a report to Congress within 180 days of enactment. The bill does not create new regulations or funding but aims to inform future energy planning for AI/data center development.
